387 related articles for article (PubMed ID: 18262761)
21. Prevention of radiation-induced xerostomia by submandibular gland transfer.
Zhang Y; Guo CB; Zhang L; Wang Y; Peng X; Mao C; Yu GY
Head Neck; 2012 Jul; 34(7):937-42. PubMed ID: 22083885
[TBL] [Abstract][Full Text] [Related]
22. Quantifying radioxerostomia: salivary flow rate, examiner's score, and quality of life questionnaire.
Al-Nawas B; Al-Nawas K; Kunkel M; Grötz KA
Strahlenther Onkol; 2006 Jun; 182(6):336-41. PubMed ID: 16703289
[TBL] [Abstract][Full Text] [Related]
23. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer.
Jellema AP; Slotman BJ; Doornaert P; Leemans CR; Langendijk JA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):751-60. PubMed ID: 17560735
[TBL] [Abstract][Full Text] [Related]
24. Rehabilitation of oral function in head and neck cancer patients after radiotherapy with implant-retained dentures: effects of hyperbaric oxygen therapy.
Schoen PJ; Raghoebar GM; Bouma J; Reintsema H; Vissink A; Sterk W; Roodenburg JL
Oral Oncol; 2007 Apr; 43(4):379-88. PubMed ID: 16996783
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation.
Rodrigues NA; Killion L; Hickey G; Silver B; Martin C; Stevenson MA; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1079-83. PubMed ID: 19327910
[TBL] [Abstract][Full Text] [Related]
26. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.
Teguh DN; Levendag PC; Noever I; van Rooij P; Voet P; van der Est H; Sipkema D; Sewnaik A; Baatenburg de Jong RJ; de la Bije D; Schmitz PI
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1119-27. PubMed ID: 18472364
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
28. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
29. Immediate impact of primary surgery on health-related quality of life of hospitalized patients with oral and oropharyngeal cancer.
Biazevic MG; Antunes JL; Togni J; de Andrade FP; de Carvalho MB; Wünsch-Filho V
J Oral Maxillofac Surg; 2008 Jul; 66(7):1343-50. PubMed ID: 18571015
[TBL] [Abstract][Full Text] [Related]
30. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
Ahmed M; Hansen VN; Harrington KJ; Nutting CM
Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
[TBL] [Abstract][Full Text] [Related]
31. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
[TBL] [Abstract][Full Text] [Related]
32. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
33. Swallowing after major surgery of the oral cavity or oropharynx: a prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction.
Borggreven PA; Verdonck-de Leeuw I; Rinkel RN; Langendijk JA; Roos JC; David EF; de Bree R; Leemans CR
Head Neck; 2007 Jul; 29(7):638-47. PubMed ID: 17274054
[TBL] [Abstract][Full Text] [Related]
34. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
de Castro G; Federico MH
Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
[TBL] [Abstract][Full Text] [Related]
35. What patients consider important: temporal variations by early and late stage oral, oropharyngeal and laryngeal subsites.
Metcalfe CW; Lowe D; Rogers SN
J Craniomaxillofac Surg; 2014 Jul; 42(5):641-7. PubMed ID: 24238983
[TBL] [Abstract][Full Text] [Related]
36. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva.
Jellema AP; Slotman BJ; Doornaert P; Leemans CR; Langendijk JA
Radiother Oncol; 2007 Oct; 85(1):83-9. PubMed ID: 17391790
[TBL] [Abstract][Full Text] [Related]
37. Health related quality of life after mandibular resection for oral and oropharyngeal squamous cell carcinoma.
Van Cann EM; Dom M; Koole R; Merkx MA; Stoelinga PJ
Oral Oncol; 2005 Aug; 41(7):687-93. PubMed ID: 15927521
[TBL] [Abstract][Full Text] [Related]
38. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy.
Yoshimura R; Shibuya H; Miura M; Watanabe H; Ayukawa F; Hayashi K; Toda K
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):772-8. PubMed ID: 18676096
[TBL] [Abstract][Full Text] [Related]
39. The role of saliva in oral health: strategies for prevention and management of xerostomia.
Brosky ME
J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
[TBL] [Abstract][Full Text] [Related]
40. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
